Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

NCT01458951 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis

NCT01465763 ·Status: COMPLETED ·Phase: PHASE3

Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.

NCT02840721 ·Status: COMPLETED ·Phase: PHASE2

Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

NCT05069259 ·Status: TERMINATED

Tofacitinib Versus Cyclosporine for Steroid Refractory Acute Severe Ulcerative Colitis

NCT05112263 ·Status: NOT_YET_RECRUITING ·Phase: NA

Tofacitinib Registry of Patients With Ulcerative Colitis in Germany

NCT04032756 ·Status: TERMINATED

Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

NCT02738125 ·Status: COMPLETED

Retrospective Observational Comparison Study Between Ustekinumab and Tofacitinib as Third Line Therapy in a Multicenter Cohort of Patients With Refractory Ulcerative Colitis.

NCT05728008 ·Status: COMPLETED

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

NCT02435992 ·Status: COMPLETED ·Phase: PHASE3

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

NCT05817942 ·Status: ACTIVE_NOT_RECRUITING

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis

NCT02888379 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

NCT01506362 ·Status: COMPLETED ·Phase: PHASE2

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

NCT05907330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects

NCT02463045 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis

NCT02289417 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03844932 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

NCT03943550 ·Status: TERMINATED ·Phase: PHASE1

Study for Safety and Tolerability of TOP1288 Administered Orally in Healthy Subjects

NCT03071081 ·Status: COMPLETED ·Phase: PHASE1

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05084261 ·Status: COMPLETED ·Phase: PHASE1

LIV001 in Patients with Mild-to-Moderate Active Ulcerative Colitis (UC)

NCT06749795 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

NCT04882007 ·Status: COMPLETED ·Phase: PHASE2

Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis

NCT03808506 ·Status: WITHDRAWN

A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Colitis

NCT04090411 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

NCT03653026 ·Status: COMPLETED ·Phase: PHASE3